Search

everythinglearnresearchcommunity

for

Search:↓

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

Optimizing the structure of a specific compound greatly improved its effectiveness and precision for treating diabetic complications.

MCP@G improves diabetic wound healing by reducing stress and promoting tissue repair.

A new hair loss treatment using dissolving microneedles was found to speed up hair growth and was more effective than daily use of common hair growth drugs.

GMG-43AC may help reduce unwanted hair growth and treat certain hair loss conditions.

Pioglitazone combined with metformin or spironolactone improves PCOS symptoms and insulin resistance.

Inhibiting PDE8A may help treat hair loss by boosting fat cell growth and hair regeneration.

Thyroid receptor agonists may treat male pattern baldness without harmful side effects.

Finasteride reduces certain behaviors caused by D1-like receptor agonists but not by D2-like receptor agonists in mice.

GPR40 agonists help hair growth through the protein ANGPTL4.

Laser-assisted prostaglandin analogs improve hypopigmented scars safely, but more research is needed.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

Food-derived peptides may help prevent diseases like high blood pressure and high cholesterol, and can support the immune system.

Guselkumab effectively treats skin reactions caused by adalimumab in certain conditions.

The Blood Glucose Management Service improved patient safety and outcomes in managing blood sugar in hospitalized patients.

PROTACs show promise in cancer treatment by effectively degrading specific harmful proteins.

The system improved diabetic wound healing in rats.

Tridax procumbens significantly lowers blood sugar in diabetic rats.

Overexpressing the glucocorticoid receptor in mice leads to abnormal skin development and reduced inflammation.

Scientists created tiny particles loaded with a hair growth drug, minoxidil, that specifically target hair follicles and skin cells to potentially improve hair growth.

A new mutation in the human glucocorticoid receptor reduces its function and causes resistance to glucocorticoids.

New curcumin analogues help fight prostate cancer by breaking down androgen receptors.

Lifestyle changes are more effective than metformin for reducing type 2 diabetes risk.

A new compound shows promise as a topical treatment for hair loss.

Drug repurposing shows promise for treating many medical conditions.

Dapagliflozin helps protect heart cells under stress by improving mitochondrial function and reducing cell damage.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

Early advanced therapies are crucial for better survival in aggressive insulinoma cases.

The S1PR 1&4 modulator may effectively treat alopecia areata by reducing hair loss and immune cell activity.